WallStreetZenWallStreetZen

NASDAQ: MCRB
Seres Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Seres Therapeutics earnings were -$22.5M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest MCRB earnings report on Jun 30, 2026 announced Q2 2026 earnings of $4.6M, down 123% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MCRB reported annual earnings of $5.7M, with 4,088.2% growth. The next MCRB earnings date is Nov 4, 2026.

MCRB earnings history

Current Revenue
$1.9M
Current Earnings
-$22.5M
Current Profit Margin
-1,192.9%

MCRB Return on Equity

Current Company
-60.3%
Current Industry
-13.6%
Current Market
31%
MCRB's Return on Equity (-60.3%)... subscribe to Premium to read more.
High Return on Equity Performance

MCRB Return on Assets

Current Company
-17.9%
Current Industry
-10.2%
MCRB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MCRB announces earnings.

MCRB Return on Capital Employed

Current Company
-27.54%
Current Industry
-6.7%
MCRB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MCRB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MCRB-$10.50M-$22.46MN/A-$2.44
MREO-$27.96M-$28.10MN/A-$0.20
GRCE-$21.91M-$20.22MN/A-$1.17
KAPA-$5.66M-$5.81MN/A-$0.28
HOWL-$25.70M-$34.61MN/A-$0.72
View Top Biotech Stocks

MCRB earnings dates

Next earnings date
Nov 4, 2026

Seres Therapeutics Earnings Reports & History FAQ

What were Seres Therapeutics's earnings last quarter?

On MCRB's earnings call on Aug 5, 2026, Seres Therapeutics (NASDAQ: MCRB) reported Q2 2026 earnings per share (EPS) of $0.47, up 120.7% year over year. Total MCRB earnings for the quarter were $4.58 million. In the same quarter last year, Seres Therapeutics's earnings per share (EPS) was -$2.27.

If you're new to stock investing, here's how to buy Seres Therapeutics stock.

When does Seres Therapeutics report earnings?

The next MCRB earnings date is Nov 4, 2026. Add MCRB to your watchlist to be reminded of Seres Therapeutics's next earnings date.

Is Seres Therapeutics profitable or losing money?

As of the last Seres Therapeutics earnings report, Seres Therapeutics is currently losing money. Seres Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$22.46 million, a 126.13% decrease year over year.

What was MCRB's earnings growth in the past year?

As of Seres Therapeutics's earnings date in Aug 5, 2026, Seres Therapeutics's earnings has grown year over year. MCRB earnings in the past year totalled -$22.46 million.

What are Seres Therapeutics's earnings expectations?

The current EPS estimate for Seres Therapeutics's earnings report in Nov 4, 2026 is -$1.34.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.